申请人:Sterling Winthrop Inc.
公开号:US05380729A1
公开(公告)日:1995-01-10
1-Hetero substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.
1-杂代替的6,11-乙烷-6,11-二氢苯并[b]喹啉盐,含有它们的药物组合物,以及利用它们治疗或预防神经退行性疾病或神经毒性损伤的方法。